Recent Advances in Copper-Based Organic Complexes and Nanoparticles for Tumor Theranostics

Area of Science:

• Oncology
• Biochemistry
• Nanotechnology

Background:

• Drug-resistant cancers present unique challenges due to abnormal cell death and mutated pathways.
• Malignant cells display distinct metabolic differences compared to normal cells, notably in copper regulation.
• Elevated intracellular copper levels are a common characteristic across various cancer types.

Purpose of the Study:

• To explore the role of copper metabolism in cancer.
• To review the potential of targeting copper for novel cancer treatment strategies.
• To discuss the application of copper in cancer theranostics.

Main Methods:

• Review of scientific literature on copper metabolism in cancer.
• Analysis of preclinical studies on copper-based compounds against cancer cells.
• Synthesis of information on copper's role in cellular processes relevant to cancer.

Main Results:

• Copper plays a crucial role in maintaining cellular oxidation, protein activity, and metabolism.
• Intracellular copper accumulation is a hallmark of many cancer types.
• Preclinical data indicate that copper-based nanoparticles and metal-organic complexes exhibit anticancer activity.

Conclusions:

• Altered copper metabolism in cancer cells represents a promising therapeutic target.
• Copper-based compounds demonstrate potential for developing novel oncotherapeutic and theranostic approaches.
• Further research into copper's role in cancer could lead to innovative treatment modalities.